TY  - JOUR
AU  - Lee, Shing Fung
AU  - Luque-Fernandez, Miguel Angel
AU  - Chen, Yu Hui
AU  - Catalano, Paul J
AU  - Chiang, Chi Leung
AU  - Wan, Eric Yuk-Fai
AU  - Wong, Ian Chi-Kei
AU  - Chen, Ming Hui
AU  - Ng, Andrea K
PY  - 2020
DO  - 10.1182/bloodadvances.2020002737
UR  - http://hdl.handle.net/10668/16460
T2  - Blood advances
AB  - Evidence regarding the dose-related impact of doxorubicin on subsequent cardiovascular diseases (CVDs) in Asian patients with diffuse large B-cell lymphoma (DLBCL) without preexisting CVDs is lacking. From a territory-wide electronic database in Hong...
LA  - en
PB  - American Society of Hematology
KW  - Survivors
KW  - Cardiovascular Diseases
KW  - Doxorubicin
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Adult
KW  - Cardiovascular Diseases
KW  - Doxorubicin
KW  - Hong Kong
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Survivors
TI  - Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong.
TY  - research article
VL  - 4
ER  -